C16 DIHYDROCERAMIDE (D18:0/16:0)

Code: 860634P-5MG D2-231

Application

C16 Dihydroceramide (d18:0/16:0) is suitable for use to study the potential relevance of the changes observed in the sphingolipid composition of autophagosomes an...


 Read more

Your Price
€98.34 5MG
€120.96 inc. VAT
REQUEST

Application

C16 Dihydroceramide (d18:0/16:0) is suitable for use to study the potential relevance of the changes observed in the sphingolipid composition of autophagosomes and autolysosomes in tetrahydrocannabinol (THC) treated cells or to destabilize biological membranes.

Biochem/physiol Actions

Dihydroceramide acts as a precursor for ceramide synthesis. It has an ability to induce autophagy in the perinuclear region. Dihydroceramide affects autophagic flux and enhances the formation lipid droplets. Accumulation of C16-dihydroceramides might lead to liver injury.

Packaging

5 mL Amber Glass Screw Cap Vial (860634P-5mg)

5 mL Amber Glass Screw Cap Vial (860634P-10mg)

formpowder
manufacturer/tradenameAvanti Polar Lipids 860634P
packagingpkg of 1 × 10 mg (860634P-10mg), pkg of 1 × 5 mg (860634P-5mg)
shipped indry ice
SMILES stringOC[C@]([H])(NC(CCCCCCCCCCCCCCC)=O)[C@]([H])(O)CCCCCCCCCCCCCCC
storage temp.−20°C
Cas Number5966-29-0
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.